Gregory C Miller, Nneoma S Wamkpah, Ashley B Weinhold, David S Leonard, Judith E C Lieu, Jacob D AuBuchon
{"title":"A Retrospective Analysis of Superficial Cervical Plexus Blockade for Children Undergoing Otologic Surgery.","authors":"Gregory C Miller, Nneoma S Wamkpah, Ashley B Weinhold, David S Leonard, Judith E C Lieu, Jacob D AuBuchon","doi":"10.1002/pne2.70002","DOIUrl":null,"url":null,"abstract":"<p><p>Superficial cervical plexus blocks (SCPB) are well documented for anterior and lateral neck surgeries in adults. Their role in the pediatric population is less clear. Our objective was to determine whether superficial cervical plexus blockade reduced postoperative nausea and vomiting (PONV) in children undergoing otologic surgery. This single-center retrospective cohort study evaluated patients aged 1-18 years old undergoing cochlear implantation, tympanomastoidectomy, tympanoplasty, or myringoplasty via a postauricular incision over a 27-month period. Patients undergoing bilateral surgery, concurrent surgery (exclusive of myringotomy or endoscopic otologic procedures), or transcanal-only otologic procedures were excluded. The primary outcome was PONV as measured by antiemetic use or documented nausea or vomiting among patients who received a SCPB compared to patients who did not receive a block. Secondary outcomes included opioid use, length of stay in the postoperative anesthesia care unit and hospital, time to oral intake, postoperative pain scores, and adverse events. Multilinear regression analyzed the effect of independent variables on the primary outcome. Analyses were stratified by surgery type. A total of 237 patients met inclusion criteria; 121 patients (51%) received a SCPB. There was no statistically significant difference in PONV outcomes between the two groups (proportion difference 4.5%, 95% CI -7.5% to 16.5%) despite lower intraoperative opioid administration to patients in the SCPB group (intravenous morphine equivalents per kg -0.04 mg, 95% CI -0.08 to 0, <i>p</i> = 0.030). Addition of a SCPB did not reduce PONV for pediatric patients undergoing otologic surgery via a postauricular incision. No adverse events were attributed to the block in this study.</p>","PeriodicalId":94166,"journal":{"name":"Paediatric & neonatal pain","volume":"7 1","pages":"e70002"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11828746/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatric & neonatal pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pne2.70002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Superficial cervical plexus blocks (SCPB) are well documented for anterior and lateral neck surgeries in adults. Their role in the pediatric population is less clear. Our objective was to determine whether superficial cervical plexus blockade reduced postoperative nausea and vomiting (PONV) in children undergoing otologic surgery. This single-center retrospective cohort study evaluated patients aged 1-18 years old undergoing cochlear implantation, tympanomastoidectomy, tympanoplasty, or myringoplasty via a postauricular incision over a 27-month period. Patients undergoing bilateral surgery, concurrent surgery (exclusive of myringotomy or endoscopic otologic procedures), or transcanal-only otologic procedures were excluded. The primary outcome was PONV as measured by antiemetic use or documented nausea or vomiting among patients who received a SCPB compared to patients who did not receive a block. Secondary outcomes included opioid use, length of stay in the postoperative anesthesia care unit and hospital, time to oral intake, postoperative pain scores, and adverse events. Multilinear regression analyzed the effect of independent variables on the primary outcome. Analyses were stratified by surgery type. A total of 237 patients met inclusion criteria; 121 patients (51%) received a SCPB. There was no statistically significant difference in PONV outcomes between the two groups (proportion difference 4.5%, 95% CI -7.5% to 16.5%) despite lower intraoperative opioid administration to patients in the SCPB group (intravenous morphine equivalents per kg -0.04 mg, 95% CI -0.08 to 0, p = 0.030). Addition of a SCPB did not reduce PONV for pediatric patients undergoing otologic surgery via a postauricular incision. No adverse events were attributed to the block in this study.
浅表颈丛阻滞(SCPB)在成人前颈和侧颈手术中有很好的文献记载。它们在儿科人群中的作用尚不清楚。我们的目的是确定浅表颈丛阻滞是否能减少接受耳科手术的儿童术后恶心和呕吐(PONV)。这项单中心回顾性队列研究评估了年龄在1-18岁的患者在27个月的时间里接受了耳蜗植入、鼓室乳突切除术、鼓室成形术或耳膜成形术。排除了接受双侧手术、同时手术(不包括鼓膜切开术或内窥镜耳科手术)或仅经耳手术的患者。主要结局是接受SCPB的患者与未接受SCPB的患者相比,通过止吐剂使用或记录的恶心或呕吐来测量PONV。次要结局包括阿片类药物的使用、在术后麻醉护理单位和医院的停留时间、口服时间、术后疼痛评分和不良事件。多元线性回归分析了自变量对主要结局的影响。分析按手术类型分层。共有237例患者符合纳入标准;121例(51%)患者接受了SCPB。尽管SCPB组患者术中给药阿片类药物较少(静脉吗啡当量每公斤-0.04 mg, 95% CI -0.08至0,p = 0.030),但两组间PONV结果无统计学差异(比例差异为4.5%,95% CI -7.5%至16.5%)。对于通过耳后切口接受耳科手术的儿童患者,增加SCPB并没有降低PONV。在本研究中,没有不良事件归因于阻滞。